Abstract
Osteoclasts are large, multinucleated, terminally differentiated cells formed by the fusion of mononuclear hemopoietic precursors. Their function is the resorption of bone, which is an essential part of the growth, modeling and remodeling of the skeleton. Though some osteoclast differentiation factors have recently been identified, the molecular basis for the fusion process that leads to multinucleation is poorly understood. The ATP-gated P2X7 receptor is a plasma membrane receptor belonging to the family of P2X purinergic receptors. It is known to be expressed by cells of hemopoietic origin where its activation leads to multiple downstream events including cytokine release, cell permeabilization and apoptosis. More recently this receptor has been implicated in the generation of multinucleated giant cells and polykaryons. Here we show that human osteoclasts express P2X7 receptors in vitro and in vivo, and that these receptors are functional in vitro, as assessed by pore-formation studies. More importantly, blockade of the P2X7 receptor with the antagonist oxidized ATP or a blocking monoclonal antibody significantly inhibits the fusion of osteoclast precursors to form multinucleated osteoclasts. Taken in combination with previous results from our laboratory demonstrating P2X7 receptor-mediated apoptosis and inhibition of bone resorption in vitro, these data suggest an important role for the P2X7 receptor in the regulation of the osteoclast population. The P2X7 receptor provides a significant new target for modulating osteoclast function in diseases characterized by increased osteoclast number and excessive bone turnover.
Similar content being viewed by others
References
A Lindunger CA Mackay B Ekrylander G Andersson SC Marks (1990) ArticleTitleHistochemistry and biochemistry of tartrate-resistant acid-phosphatase (TRAP) and tartrate-resistant acid adenosine-triphosphatase (TRATPASE) in bone, bone-marrow and spleen — implications for osteoclast ontogeny. J Bone Miner Res 10 109–119 Occurrence Handle1:CAS:528:DyaK3cXmt1yns70%3D
GC Nicholson MA Horton PM Sexton CS D’Santos JM Moseley BE Kemp JA Pringle TJ Martin (1987) ArticleTitleCalcitonin receptor of human osteoclastoma. Horm Metab Res 19 585–589 Occurrence Handle1:CAS:528:DyaL1cXmvFChuw%3D%3D Occurrence Handle2828212
G Mundy (1996) Bone resorbing cells. MJ Favus (Eds) Primer on the metabolic bone diseases and disorders of mineral metabolism. Lippencott-Raven Philadelphia and New York 16–24
DL Lacey E Timms H-L Tan et al. (1998) ArticleTitleOsteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93 165–176 Occurrence Handle9568710
BL Riggs R Baron WJ Boyle M Drezner S Manolagas TJ Martin AF Stewart T Suda H Yasuda J Aubin D Goltzman (2000) ArticleTitleProposed standard nomenclature for new tumor necrosis factor family members involved in the regulation of bone resorption. J Bone Miner Res 15 2293–2296 Occurrence Handle1:CAS:528:DC%2BD3cXovVShs70%3D Occurrence Handle11127193
Y Fujikawa JMW Quinn A Sabokbar JO McGee NA Athanasou (1996) ArticleTitleThe human osteoclast precursor circulates in the monocyte fraction. Endocrinology 137 4058–4060 Occurrence Handle1:CAS:528:DyaK28Xlt1Khtrs%3D Occurrence Handle8756585
DM Biskobing X Fan J Rubin (1995) ArticleTitleCharacterization of MCFS-induced proliferation and subsequent osteoclast formation in murine marrow culture. J Bone Miner Res 10 1025–1032 Occurrence Handle1:STN:280:BymD1c3jsVQ%3D Occurrence Handle7484277
F Rassendren GN Buell C Virginio G Collo RA North A Surprenant (1997) ArticleTitleThe permeabilizing ATP receptor (P2X7): cloning and expression of human cDNA. J Biol Chem 272 5482–5486 Occurrence Handle1:CAS:528:DyaK2sXhslalsr0%3D Occurrence Handle9038151
F Di Virgilio (1995) ArticleTitleThe P2Z purinoceptor-an intriguing role in immunity, inflammation and cell-death. Immunol Today 16 524–528 Occurrence Handle10.1016/0167-5699(95)80045-X Occurrence Handle1:CAS:528:DyaK2MXptFehsbc%3D Occurrence Handle7495489
IP Chessell AD Michel PPA Humphrey (1998) ArticleTitleEffects of antagonist at the human recombinant P2X7 receptor. Br J Pharmacol 124 1314–1320 Occurrence Handle1:CAS:528:DyaK1cXltFGltrg%3D Occurrence Handle9720806
D Ferrari P Chiozzi S Falzoni S Hanau F Di Virgilio (1997) ArticleTitlePurinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J Exp Med 185 579–582 Occurrence Handle10.1084/jem.185.3.579 Occurrence Handle1:CAS:528:DyaK2sXhtFWktrg%3D Occurrence Handle9053458
LM Zheng A Zychlinsky CC Liu DM Ojcius JD Young (1991) ArticleTitleExtracellular ATP as a trigger for apoptosis or programmed cell death. J Cell Biol 112 279–288 Occurrence Handle1:CAS:528:DyaK3MXlvFKnsw%3D%3D Occurrence Handle1988462
F Di Virgilio S Falzoni P Chiozzi JM Sanz D Ferrari GN Buell (1999) ArticleTitleATP receptor and giant cell formation. J Leukoc Biol 66 723–726 Occurrence Handle1:CAS:528:DyaK1MXnsVanurc%3D Occurrence Handle10577500
S Falzoni P Chiozzi D Ferrari GN Buell F Di Virgilio (2000) ArticleTitleP2X(7) receptor and polykarion formation. Mol Biol Cell 11 3169–3176 Occurrence Handle1:CAS:528:DC%2BD3cXmvFShsrs%3D Occurrence Handle10982408
WE Modderman AF Weidema T Vrijheid-Lammers AM Wassenaar PJ Nijweide (1994) ArticleTitlePermeabilization of cells of hemopoietic origin by extracellular ATP4-: elimination of osteoclasts, macrophages, and their precursors from isolated bone cell populations and fetal bone rudiments. Calcif Tissue Int 55 141–150 Occurrence Handle1:CAS:528:DyaK2cXmt1Ohu7o%3D Occurrence Handle7953980
A Hoebertz A Townsend-Nicholson R Glass G Burnstock TR Arnett (2000) ArticleTitleExpression of P2 receptors in bone and cultured bone cells. Bone 27 503–510 Occurrence Handle10.1016/S8756-3282(00)00351-3 Occurrence Handle1:CAS:528:DC%2BD3cXnt1Sjtrk%3D Occurrence Handle11033445
A Gartland JA Gallagher WB Bowler (2000) ArticleTitleExpression of the pore-forming P2X7 receptor by human giant cell tumour, osteoclasts and human RANKL-generated osteoclasts. J Bone Miner Res 15 1227
LN Naemsch SJ Dixon SM Sims (2001) ArticleTitleActivity-dependent development of P2X7 current and Ca2+ entry in rabbit osteoclasts. J Biol Chem 276 39107–39114 Occurrence Handle10.1074/jbc.M105881200 Occurrence Handle1:CAS:528:DC%2BD3MXnvVems78%3D Occurrence Handle11495918
K Matsuzaki N Udagawa N Takahashi K Yamaguchi H Yasuda N Shima T Morinaga Y Toyama Y Yabe K Higashio T Suda (1998) ArticleTitleOsteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Biochem Biophys Res Commun 246 199–204
A Gartland RA Hipskind JA Gallagher WB Bowler (2001) ArticleTitleExpression of a functional P2X7 receptor by a sub-population of human osteoblasts. J Bone Miner Res 16 846–856 Occurrence Handle1:CAS:528:DC%2BD3MXjs1Wjtbk%3D Occurrence Handle11341329
G Buell IP Chessell AD Michel G Collo M Salazzo S Herren D Gretener C Grahames R Kaur MH Kosco-Vilbois PP Humphrey (1998) ArticleTitleBlockade of human P2X7 receptor function with a monoclonal antibody. Blood 92 3521–3528 Occurrence Handle1:CAS:528:DyaK1cXnsVKlsL4%3D Occurrence Handle9808543
CA Walsh JN Beresford MA Birch B Boothroyd JA Gallagher (1991) ArticleTitleApplication of reflected light microscopy to identify and quantitate resorption by isolated osteoclasts. J Bone Miner Res 6 661–671 Occurrence Handle1:STN:280:By2D2MfgvFM%3D Occurrence Handle1950671
CB Grahames AD Michel IP Chessell PP Humphrey (1999) ArticleTitlePharmacological characterization of ATP- and LPS-induced IL-1beta release in human monocytes. Br J Pharmacol 127 1915–1921 Occurrence Handle1:CAS:528:DyaK1MXmtVart70%3D Occurrence Handle10482924
BJ Gu W Zhang RA Worthington R Sluyter P Dao-Ung S Petrou JA Barden JS Wiley (2001) ArticleTitleA Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor. J Biol Chem 276 11135–11142 Occurrence Handle10.1074/jbc.M010353200 Occurrence Handle1:CAS:528:DC%2BD3MXjvFGjs7s%3D Occurrence Handle11150303
BD Humphreys GR Dubyak (1998) ArticleTitleModulation of P2X7 receptor expression by pro- and anti-inflammatory stimuli in THP-1 monocytes. J Leukocyte Biol 64 265–273 Occurrence Handle1:CAS:528:DyaK1cXltFyls7g%3D Occurrence Handle9715267
TH Steinberg AS Newman JA Swanson SC Silverstein (1987) ArticleTitleATP4− permeabilizes the plasma-membrane of mouse macrophages to fluorescent dyes. J Biol Chem 262 8884–8888 Occurrence Handle1:CAS:528:DyaL2sXksFKlsro%3D Occurrence Handle3597398
AD Michel M Xing PP Humphrey (2001) ArticleTitleSerum constituents can affect 2′-& 3′-O-(4-benzoylbenzoyl)-ATP potency at P2X(7) receptors. Br J Pharmacol 132 1501–1508 Occurrence Handle1:CAS:528:DC%2BD3MXivVahsLw%3D Occurrence Handle11264244
N Chaib E Kabre E Alzola S Pochet JP Dehaye (2000) ArticleTitleBromoenol lactone enhances the permeabilization of rat submandibular acinar cells by P2X7 agonists. Br J Pharmacol 129 703–708 Occurrence Handle1:CAS:528:DC%2BD3cXhslWqsL0%3D Occurrence Handle10683195
JS Wiley CE Gargett W Zhang MB Snook GP Jamieson (1998) ArticleTitlePartial agonists and antagonists reveal a second permeability state of human lymphocyte P2Z/P2X7 channel. Am J Physiol 275 C1224–C1231 Occurrence Handle1:CAS:528:DyaK1cXns1aitLg%3D Occurrence Handle9814970
BD Humphreys C Virginio A Surprenant J Rice GR Dubyak (1998) ArticleTitleIsoquinolines as antagonists of the P2X7 nucleotide receptor: high selectivity for the human versus rat receptor homologues. Mol Pharmacol 54 22–32 Occurrence Handle1:CAS:528:DyaK1cXkvVKqsbg%3D Occurrence Handle9658186
T Hirayama A Sabokbar NA Athanasou (2002) ArticleTitleEffect of corticosteroids on human osteoclast formation and activity. J Endocrinol 175 IssueID1 155–163 Occurrence Handle1:CAS:528:DC%2BD38XosVKjsro%3D Occurrence Handle12379499
P Orcel M Feuga J Bielakoff MC De Vernejoul (1993) ArticleTitleLocal bone injections of LPS and M-CSF increase bone resorption by different pathways in vivo in rats. Am J Physiol 264 E391–397 Occurrence Handle1:CAS:528:DyaK3sXksVWkurY%3D Occurrence Handle8460686
Y Abu-Amer FP Ross J Edwards SL Teitelbaum (1997) ArticleTitleLipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. J Clin Invest 100 1557–1565 Occurrence Handle1:CAS:528:DyaK2sXmt1Cqtrw%3D Occurrence Handle9294124
W Zou Z Bar-Shavit (2002) ArticleTitleDual modulation of osteoclast differentiation by lipopolysaccharide. JBMR 17 1211–1218 Occurrence Handle1:CAS:528:DC%2BD38XlsF2nu7w%3D
W Zou I Hakim K Tschoep S Endres Z Bar-Shavit (2001) ArticleTitleTumor necrosis factor-alpha mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism. J Cell Biochem 83 70–83 Occurrence Handle10.1002/jcb.1202 Occurrence Handle1:CAS:528:DC%2BD3MXmslWitL4%3D Occurrence Handle11500955
J Lam S Takeshita JE Barker O Kanagawa FP Ross SL Teitelbaum (2000) ArticleTitleTNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106 1481–1488 Occurrence Handle1:CAS:528:DC%2BD3cXovFagtbo%3D Occurrence Handle11120755
JM Halasy-Nagy GA Rodan AA Reszka (2001) ArticleTitleInhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis. Bone 6 553–559 Occurrence Handle10.1016/S8756-3282(01)00615-9
A Gartland AF Ginty JA Gallagher WB Bowler (1999) ArticleTitleActivation of P2X7 receptors expressed by human osteoclastoma modulates bone resorption. Calcif Tissue Int 64 S56
SL Teitelbaum JD Malone AJ Kahn (1981) ArticleTitleGlucocorticoid enhancement of bone resorption by rat peritoneal macrophages in vitro. Endocrinology 108 795–799
J Tobias TJ Chambers (1989) ArticleTitleGlucocorticoids impair bone resorptive activity and viability of osteoclasts disaggregated from neonatal rat long bones. Endocrinology 125 1290–1295 Occurrence Handle1:CAS:528:DyaL1MXlsVKqurs%3D Occurrence Handle2759026
WB Bowler JA Tattersall R Hussein CJ Dixon PH Cobbold JA Gallagher (1998) ArticleTitleReal time measurement of ATP release from human osteoblasts. J Bone Miner Res 13 525
M Romanello B Pani M Bicego P D’Andrea (2001) ArticleTitleMechanically induced ATP release from human osteoblastic cells. Biochem Biophys Res Commun 289 1275–1281 Occurrence Handle10.1006/bbrc.2001.6124 Occurrence Handle1:CAS:528:DC%2BD3MXptVWisLk%3D Occurrence Handle11741333
K Mizuno H Okamoto T Horio (2001) ArticleTitleHeightened ability of monocytes from sarcoidosis patients to form multi-nucleated giant cells in vitro by supernatants of concanavalin A-stimulated mononuclear cells. Clin Exp Immunol 126 151–156 Occurrence Handle10.1046/j.1365-2249.2001.01655.x Occurrence Handle1:STN:280:DC%2BD3MrntFWgtQ%3D%3D Occurrence Handle11678912
E Adinolfi L Melchiorri S Falzoni P Chiozzi A Morelli A Tieghi A Cuneo G Castoldi F Di Virgilio OR Baricordi (2002) ArticleTitleP2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood 15 706–708 Occurrence Handle10.1182/blood.V99.2.706
Acknowledgements
We are grateful to Prof. W.D. Fraser for supplying samples from patients under his care; J. Rice for help with the ethidium bromide uptake images; Drs. Odgren, Marks and Kramer-Haemmerle for helpful discussions, and Dr. Ivings for assistance with the manuscript. This work was supported by The University of Liverpool (A.G.), and the Arthritis Research Campaign (K.A.B.).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gartland, A., Buckley, K., Bowler, W. et al. Blockade of the Pore-Forming P2X7 Receptor Inhibits Formation of Multinucleated Human Osteoclasts In Vitro . Calcif Tissue Int 73, 361–369 (2003). https://doi.org/10.1007/s00223-002-2098-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-002-2098-y